Literature DB >> 24863031

Diagnostic use of immunohistochemistry in uterine mesenchymal tumors.

Emanuela D'Angelo1, Jaime Prat2.   

Abstract

Immunohistochemistry may be helpful in the diagnosis of mesenchymal uterine tumors. This article reviews the immunoreactions used most frequently in the diagnosis of uterine smooth muscle tumors, endometrial stromal tumors, undifferentiated endometrial sarcomas, UTROSCTs, PEComas, adenomyomas, adenosarcomas and carcinosarcomas.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; antibodies; biomarkers; immunoreaction; mesenchymal tumors; uterus

Mesh:

Substances:

Year:  2014        PMID: 24863031     DOI: 10.1053/j.semdp.2014.03.003

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  4 in total

Review 1.  Uterine Adenosarcoma: a Review.

Authors:  Michael J Nathenson; Vinod Ravi; Nicole Fleming; Wei-Lien Wang; Anthony Conley
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

2.  Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.

Authors:  Jennifer A Bennett; Ana C Braga; Andre Pinto; Koen Van de Vijver; Kristine Cornejo; Anna Pesci; Lei Zhang; Vicente Morales-Oyarvide; Takako Kiyokawa; Gian Franco Zannoni; Joseph Carlson; Tomas Slavik; Carmen Tornos; Cristina R Antonescu; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2018-10       Impact factor: 6.394

3.  Extra-uterine low grade endometrioid stromal sarcoma arising from ovarian endometriosis: a case report and review of the literature.

Authors:  Boubacar Efared; Ibrahim S Sidibé; Fatimazahra Erregad; Nawal Hammas; Laila Chbani; Hinde El Fatemi
Journal:  Gynecol Oncol Res Pract       Date:  2019-01-29

4.  A Retrospective Case Study of 13 Uterine Perivascular Epithelioid Cell Neoplasm (PEComa) Patients.

Authors:  Jiahui Gu; Wantong Wang; Shizhuo Wang
Journal:  Onco Targets Ther       Date:  2021-03-09       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.